Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2019

Feb 14, 2019

30237_dirs_2019-02-14_e877542e-d697-4424-b0dd-ff51c6f9d379.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2019-02-12

Reporting Person: Williams R Sanders (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-12 Common Stock M 1038 Acquired 8924 Direct
2019-02-13 Common Stock S 1038 $147.00 Disposed 7886 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-12 Restricted Stock Unit $ M 1038 Disposed Common Stock (1038) Direct
2019-02-12 Restricted Stock Unit $ A 1227 Acquired Common Stock (1227) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F3: The Restricted Stock Units vested fully on February 12, 2019.

F4: The Restricted Stock Units vest fully on February 12, 2020.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.